|
|
|
|
|||||
|
|
|
Thermo Fisher Scientific Inc. (NYSE:TMO) ranks among the best low volatility stocks to buy according to analysts. On July 16, TD Cowen maintained its Buy rating on Thermo Fisher Scientific Inc. (NYSE:TMO) but reduced its price target from $570 to $550. Citing current low levels and market mood, the firm believes an in-line second quarter will be enough to lift TMO shares.
According to TD Cowen, biopharma activity was typical in the second quarter and was untouched by tariff or MFN issues, which the firm considers to be encouraging news. With expectations for “similar” organic growth to the first quarter, the firm reduced its second-quarter organic growth estimate from 1.2% to 1.0%, which was lower than the analysts’ consensus of 0.7%.
One of the top biotech and life sciences companies in the United States, Thermo Fisher Scientific Inc. (NYSE:TMO) offers a broad range of products and services. The company has grown significantly since its founding, mostly as a result of a number of well-timed acquisitions, such as those of Affymetrix and Life Technologies.
While we acknowledge the potential of TMO as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you’re looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the best short-term AI stock.
Read More: 10 Best Magic Formula Stocks for 2025 and 10 Best Retirement Stocks to Buy According to Hedge Funds
Disclosure: None.
| 2 hours | |
| Jul-28 | |
| Jul-28 | |
| Jul-28 | |
| Jul-28 | |
| Jul-28 | |
| Jul-28 | |
| Jul-28 | |
| Jul-26 | |
| Jul-25 | |
| Jul-25 | |
| Jul-24 | |
| Jul-24 | |
| Jul-24 | |
| Jul-24 |
Join thousands of traders who make more informed decisions with our premium features. Real-time quotes, advanced visualizations, backtesting, and much more.
Learn more about FINVIZ*Elite